CClinicalTrials.gg
Sign In
Not yet recruitingNCT06753695Updated Dec 31, 2024

Prevalence of Hypomineralized Second Primary Molars and Their Association with Dental Hypersensitivity in Egyptian Children

An observational study in Hypomineralized Second Primary Molars and Dental Hypersensitivity, sponsored by Cairo University. Not yet recruiting. Open to participants aged 4 Years to 9 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-31.

Sponsored by Cairo University · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 7 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
825
Ages
4 Years to 9 Years
Sex
All
01

Study summary

hypomineralized second primary molars and dental hypersensitivity in a group of Egyptian children

Read the detailed description

the prevalence of the condition of hypomineralized second primary molars in a group of Egyptian children and the association of this condition to dental hypersensitivity.

02

Conditions studied

  • Hypomineralized Second Primary Molars
  • Dental Hypersensitivity

Browse trials for

Keywords

  • HSPM
  • DH
  • hypo-mineralized second primary molars
  • hypomineralized E
03

In context

Hypersensitivity

1,916 studies on the registry are indexed under Hypersensitivity; 265 are open to participants now.

This study's planned enrollment of 825 is above the median of 115 across 479 observational studies indexed under Hypersensitivity.

Browse Hypersensitivity studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 9 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

a group of gentian children aged form4 to 9 years old

Inclusion criteria

  • Egyptian children
  • cooperative patients both genders and included 4-9 years old children at least one HSPM affected molar and one non affected molar absence of syndromes or craniofacial anomalies

Exclusion criteria

Exclusion Criteria:

  • other developmental defects(amelogensis imperfecta ...) children ongoing anti-inflammatory drugs children who caregiver will not sign the informed consent
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
825 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. EAPD scoring criteria and wurzberg scroring system

    present/absent of the condition

    Time frame: 1 year

Secondary outcomes

  1. VAS scale and SCASS scale

    measuring dental hypersensitivity using VAS scale and SCASS scale to reach for an association of dental hypersensitivity and HSPM

    Time frame: 1year

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Icf, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 31, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06753695
Lead sponsor
Cairo University
Responsible party
Aya Mamdouh Ibrahim (Dentist and Principal Investigato, Cairo University) — Principal investigator
First posted
Dec 31, 2024
Start date
Mar 2025 (estimated)
Primary completion
Mar 2025 (estimated)
Completion
Apr 2025 (estimated)
Last update
Dec 31, 2024

Study contacts

Aya M Ibrahim, B.D.S.
Contact
aya.mamdouh@dentistry.edu.cu.eg
+2001003396390
Aya M Ibrahim, B.D.S.
principal investigator · University of Cairo, Department of Dentistry.

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Hypersensitivity→

Other studies from this sponsor

Cairo University

Start the discussion